Non-cystic fibrosis bronchiectasis: etiology and predictors of exacerbations and mortality in patients across the largest health system in central and western Massachusetts

J. Lee (Providence, United States of America)

Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Lee (Providence, United States of America). Non-cystic fibrosis bronchiectasis: etiology and predictors of exacerbations and mortality in patients across the largest health system in central and western Massachusetts. 4061

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Incidence and resource utilisation of pulmonary exacerbations in patients with cystic fibrosis in the UK
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010

Predictors of non-cystic fibrosis bronchiectasis in Indigenous adult residents of central Australia: results of a case–control study
Source: ERJ Open Res, 5 (4) 00001-2019; 10.1183/23120541.00001-2019
Year: 2019



Exacerbations, hospitalisations and mortality in patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Year: 2017



Hospital admissions are linked to a poor health related quality of life in patients with non cystic fibrosis bronchiectasis
Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host
Year: 2007


Factors associated with recurrence of severe exacerbations in Non-cystic fibrosis bronchiectasis in developping countries.
Source: International Congress 2019 – Clinical problems
Year: 2019

The outcome of patients with COPD admitted to UK hospitals with an exacerbation. Results from the RCP/BTS national COPD audit
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005


Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017

Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020

Clinical characteristics and health burden of patients with chronic obstructive pulmonary disease exacerbation
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015

The prevalence of non-cystic fibrosis bronchiectasis in a pediatric respiratory unit
Source: International Congress 2018 – Orphan diseases in children
Year: 2018


Anxiety and low health status are predictors of exacerbations in patients with obstructive pulmonary disease
Source: Annual Congress 2006 - Muscles, training and rehabilitation
Year: 2006


The relevance of chronic obstructive pulmonary disease on mortality in patients with community acquired pneumonia
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010


The effect of transition from a paediatric to adult cystic fibrosis (CF) centre on clinical status and hospital attendance
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016

DLCO predicts disease severity and mortality in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015

Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe
Source: ERJ Open Res, 7 (4) 00411-2021; 10.1183/23120541.00411-2021
Year: 2021



The impact of bronchiectasis on outcomes in a large cohort of patients hospitalised with exacerbations of COPD
Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients
Year: 2013

Incidence of idiopathic pulmonary fibrosis in Italy. Analysis of hospital admission and mortality databases of a large Italian region
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

Assessing response to treatment of exacerbations of bronchiectasis in adults
Source: Eur Respir J 2009; 33: 312-318
Year: 2009



The effect of unit organisation and resources on outcomes of hospital admission for COPD exacerbations
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005


Non-cystic fibrosis bronchiectasis in children
Source: Annual Congress 2005 - MP11 - Non-cystic fibrosis bronchiectasis in children
Year: 2005